New Antibiotic Shows Promise Against Drug-Resistant Bacteria

Researchers at Washington University develop a compound that effectively treats severe infections in mice, including flesh-eating disease.

The compound, GmPcide, targets gram-positive bacteria, which cause various dangerous infections.
Mice treated with GmPcide showed better recovery metrics compared to untreated ones.
GmPcide damages bacterial cell membranes, reducing their virulence and aiding immune response.
The compound appears less likely to lead to drug-resistant strains, a major advantage.
Extensive testing and clinical trials are needed before GmPcide can be marketed.